Upcoming Events:

**Postponed due to weather - see below for new date** Skills Development Workshop with Regeneron Pharmaceuticals

The Harvard Biotech Club is hosting a skills development workshop led by industry professionals. Come meet representatives from Regeneron’s Talent Acquisition team and learn the skills needed to land a position in biotech! Topics discussed include how to search for a career, how to prepare a CV, and how to interview. One-on-one breakout sessions with Regeneron representatives to follow. See the attached flyer for more information.

When: Thursday, February 23 at 12:30-1:30pm followed by breakout sessions from 1:30-2:00pm

Location: TMEC 227, Harvard Medical School

Lunch will be served

Please RSVP here: https://goo.gl/forms/7aGNwUojUMnjC2OO2

Presenters from Regeneron:
Chad Barney - Lead Talent Acquisition Specialist
Natalie Griffith - Senior Manager University Relations
Sam Luo - Talent Acquisition Specialist
Alanna Nolan - Senior University Relations Specialist
Regina Thomas - Director Talent Acquisition

About Regeneron:

Regeneron is a leading science and technology company delivering life-transforming medicines for serious diseases. Founded by physician-scientists nearly 30 years ago, our science-driven approach has resulted in four FDA-approved medicines and numerous product candidates in a range of diseases, including ophthalmology, rheumatoid arthritis, atopic dermatitis, asthma, pain, cancer and infectious diseases.

**Postponed due to weather - see below for new date** Venture Capital 101: Featuring Frank T. Gentile, PhD, Venture Partner at Third Rock Ventures

What is venture capital in the life sciences and what is it like to work in that space? Join us for a discussion of venture capital in the life sciences followed by a Q&A session.

WHEN: Tuesday, March 21 at 5-6:30 pm

WHERE: Cannon Room, Building C, Harvard Medical School

Dinner will be provided. RSVP at: https://goo.gl/forms/f67N1ShxBTcqXXCr1

Speaker Bio:

Dr. Frank Gentile joined Third Rock Ventures in 2015 to focus on research and development opportunities throughout the portfolio. He brings nearly 25 years of experience working with pharmaceutical and biotechnology companies to oversee and execute biotechnology and healthcare investments in public and private companies.

Third Rock Ventures is a premier life sciences venture capital firm. With over $1.3 billion raised since it started in 2007, Third Rock Ventures has assembled an entrepreneurial team with deep expertise and a proven track record of building some of the most respected and successful life sciences companies.